ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,237Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 2343

$1.62M Total Retail Price of All Prescriptions

Rank: 16 out of 2343

641 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

22% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 25,613 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 2,078 1,875 1 8
FUROSEMIDE 1,063 972 2 6
LEVOTHYROXINE SODIUM 1,050 896 3 2
LISINOPRIL 998 844 4 3
METOPROLOL TARTRATE 965 770 5 7
SIMVASTATIN 902 738 6 1
HYDROCODONE-ACETAMINOPHEN 718 645 S3 7 13
OMEPRAZOLE 701 551 8 4
AMLODIPINE BESYLATE 639 560 9 5
POTASSIUM CHLORIDE 570 539 10 18
METFORMIN HCL 532 438 11 9
FENTANYL 492 447 S2 12 69
CITALOPRAM HBR 462 337 13 17
DONEPEZIL HCL 457 452 14 21
LANTUS 395 259 15 51
ATORVASTATIN CALCIUM 369 314 16 10
NAMENDA 328 307 17 36
GABAPENTIN 314 262 18 16
TRAZODONE HCL 313 291 19 53
MIRTAZAPINE 306 279 20 41
RISPERIDONE 291 192 21 61
SPIRIVA 267 258 22 48
METOPROLOL SUCCINATE 265 246 23 14
LACTULOSE 244 207 24 139
GLIMEPIRIDE 238 201 25 45
DIGOXIN 228 221 26 35
ALENDRONATE SODIUM 227 196 27 28
CLOPIDOGREL 224 211 28 26
PANTOPRAZOLE SODIUM 211 182 29 22
MELOXICAM 209 173 30 68
OXYCODONE-ACETAMINOPHEN 200 173 S2 31 49
SERTRALINE HCL 199 136 32 20
CARBIDOPA-LEVODOPA 194 155 33 85
HYDROCHLOROTHIAZIDE 184 159 34 11
ADVAIR DISKUS 181 156 35 34
ABILIFY 179 132 36 159
SULFAMETHOXAZOLE-TRIMETHOPRIM 166 136 37 120
DIVALPROEX SODIUM 163 93 38 105
TRAMADOL HCL 161 132 39 25
CARVEDILOL 160 146 40 27
EXELON 158 152 41 129
PRAVASTATIN SODIUM 152 103 42 15
FLUTICASONE PROPIONATE 152 107 42 46
CYMBALTA 151 138 44 74
ALLOPURINOL 150 126 45 31
LEVETIRACETAM 149 65 46 104
PLAVIX 148 146 47 38
PREDNISONE 144 136 48 37
ISOSORBIDE MONONITRATE ER 143 123 49 32
DIOVAN 140 137 50 23
LOVAZA 139 61 51 113
LIDODERM 137 135 52 130
ATENOLOL 130 130 53 12
LEVOFLOXACIN 130 117 53 106
TAMSULOSIN HCL 128 128 55 29
CRESTOR 126 104 56 30
ZOLPIDEM TARTRATE 126 101 56 24
JANUVIA 124 107 58 50
DIOVAN HCT 120 120 59 63
FAMOTIDINE 115 89 60 60
HUMALOG 115 74 60 131
CEPHALEXIN 114 86 62 111
LIPITOR 110 104 63 78
ESCITALOPRAM OXALATE 108 97 64 55
IPRATROPIUM-ALBUTEROL 107 101 65 99
NEXIUM 107 103 65 33
AMITIZA 106 84 67 304
DILTIAZEM 24HR CD 104 100 68 83
TRICOR 104 55 68 96
PAROXETINE HCL 103 69 70 66
PHENYTOIN SODIUM EXTENDED 103 103 70 152
SPIRONOLACTONE 103 84 70 65
MORPHINE SULFATE 100 100 S2 73 312
NOVOLIN N 100 70 73 300
BACLOFEN 98 46 75 161
AMIODARONE HCL 98 93 75 158
QUETIAPINE FUMARATE 96 95 77 77
NOVOLOG 94 83 78 110
EXFORGE 93 76 79 163
OLANZAPINE 93 93 79 121
BUMETANIDE 92 87 81 91
MEGESTROL ACETATE 92 90 R 81 246
BENZTROPINE MESYLATE 91 39 R 83 224
HUMULIN N 89 66 84 343
MORPHINE SULFATE ER 89 81 S2 84 142
AMLODIPINE BESYLATE-BENAZEPRIL 86 58 86 59
CLONIDINE HCL 85 65 87 70
ZETIA 84 64 88 52
METOCLOPRAMIDE HCL 80 56 89 168
AMOX TR-POTASSIUM CLAVULANATE 80 63 89 160
LAMOTRIGINE 77 66 91 194
ACTOS 74 52 92 125
METOLAZONE 71 68 93 173
OXYBUTYNIN CHLORIDE 71 58 93 169
GLUCAGEN 71 59 93 469
TRIAMCINOLONE ACETONIDE 69 62 96 137
HYDRALAZINE HCL 69 69 96 92
FLUOXETINE HCL 68 68 98 82
KLOR-CON M20 68 64 98 44
AZITHROMYCIN 67 53 100 39
VENLAFAXINE HCL ER 67 64 100 87
LOSARTAN POTASSIUM 66 45 102 19
NYSTATIN 65 61 103 172
FINASTERIDE 62 62 104 80
ALBUTEROL SULFATE 62 59 104 126
DILTIAZEM ER 60 52 106 207
CLOZAPINE 60 41 106 245
SINGULAIR 59 52 108 100
NOVOLIN 70-30 59 58 108 268
LABETALOL HCL 58 42 110 153
TOPIRAMATE 57 27 111 220
NITROFURANTOIN MONO-MACRO 56 35 112 244
CARAFATE 56 56 112 315
SEROQUEL 53 51 114 171
PHENYTOIN 53 22 114 380
WELCHOL 53 53 114 233
SYNTHROID 52 36 117 40
NITROGLYCERIN PATCH 52 52 117 147
PROPRANOLOL HCL 51 51 119 132
OXYCODONE HCL-ACETAMINOPHEN 51 15 S2 119 136
AGGRENOX 50 43 121 174
GALANTAMINE HBR 50 50 121 302
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.